- Home
- APLT vs FRD Comparison
APLT vs FRD Comparison
Compare APLT & FRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- FRD
- Stock Information
- Founded
- APLT 2016
- FRD 1965
- Country
- APLT United States
- FRD United States
- Employees
- APLT N/A
- FRD N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- FRD Steel/Iron Ore
- Sector
- APLT Health Care
- FRD Industrials
- Exchange
- APLT Nasdaq
- FRD Nasdaq
- Market Cap
- APLT 178.6M
- FRD 159.1M
- IPO Year
- APLT 2019
- FRD N/A
- Fundamental
- Price
- APLT $0.26
- FRD $19.67
- Analyst Decision
- APLT Buy
- FRD
- Analyst Count
- APLT 5
- FRD 0
- Target Price
- APLT $4.13
- FRD N/A
- AVG Volume (30 Days)
- APLT 24.7M
- FRD 20.9K
- Earning Date
- APLT 11-13-2025
- FRD 11-10-2025
- Dividend Yield
- APLT N/A
- FRD 0.81%
- EPS Growth
- APLT N/A
- FRD 43.48
- EPS
- APLT N/A
- FRD 1.63
- Revenue
- APLT $1,000,000.00
- FRD $510,450,000.00
- Revenue This Year
- APLT N/A
- FRD N/A
- Revenue Next Year
- APLT $5,935.35
- FRD N/A
- P/E Ratio
- APLT N/A
- FRD $11.86
- Revenue Growth
- APLT N/A
- FRD 8.72
- 52 Week Low
- APLT $0.22
- FRD $12.24
- 52 Week High
- APLT $10.48
- FRD $23.50
- Technical
- Relative Strength Index (RSI)
- APLT 27.74
- FRD 43.89
- Support Level
- APLT $0.26
- FRD $19.65
- Resistance Level
- APLT $0.40
- FRD $20.60
- Average True Range (ATR)
- APLT 0.12
- FRD 1.32
- MACD
- APLT -0.07
- FRD -0.25
- Stochastic Oscillator
- APLT 4.83
- FRD 14.39
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About FRD Friedman Industries Inc.
Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.